Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.16% during 2022-2028. The rising number of genomic research activities, increasing prevalence of chronic diseases, and rising focus on virtual biobank represent some of the key factors driving the market.
Biobanking refers to the process wherein samples of bodily fluid or tissue are collected, stored, annotated, and redistributed for research to improve the understanding of health and disease. It is a reliable hub of samples and enables access to a pool of high-quality samples and associated data. It is essential for the diagnosis and production of medicines for numerous disorders. It provides a basis for improving personalized medical approaches wherein effective biomarker identification is vital for disease diagnosis and prognosis. It serves as a mediator between donor and researcher for numerous research and different studies. It has high-quality control and assists in improving the reproducibility of various experiments. It also offers data generated through biosamples that is crucial for the digital transformation of health systems. As a result, biobanking is widely utilized in drug and biomarker development, clinical care for therapy, and clinical trials monitoring for the effects of drugs on eventual outcomes across the globe.
Biobanking Market Trends:
At present, the rising demand for biobanking due to the increasing number of genomic research activities represents one of the key factors supporting the growth of the market. Besides this, the growing number of biobanks across the globe, due to its potential to enhance the reproductivity and meaning of data generated by biomedical research, is offering a positive market outlook. Additionally, there is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, cancer, heart attack, and respiratory disorders, among the masses around the world. This, coupled with the increasing demand for biobanking to develop diagnostics that can effectively identify pathogens, is propelling the growth of the market. Apart from this, the rising expenditure in advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, is offering lucrative growth opportunities to industry investors. Moreover, the increasing demand for biospecimens from clinical labs to develop assays for genetic testing is positively influencing the market. In addition, the growing focus on virtual biobank that minimizes time constraints, generates high revenue, and allows researchers to conduct the research smoothly is contributing to the growth of the market. Furthermore, key players are introducing a biobank software solution that assists in gaining visibility and improving the quality of the service provided to customers, which is strengthening the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on specimen type, biobank type, application and end user.
Specimen Type Insights:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others
The report has provided a detailed breakup and analysis of the biobanking market based on the specimen type. This includes blood products, solid tissue, cell lines, nucleic acid, and others. According to the report, blood products represented the largest segment.
Biobank Type Insights:
Population-based Biobanks
Disease-oriented Biobanks
A detailed breakup and analysis of the biobanking market based on the biobank type has also been provided in the report. This includes population-based biobanks and disease-oriented biobanks. According to the report, disease-oriented biobanks accounted for the largest market share.
Application Insights:
Therapeutics
Research
A detailed breakup and analysis of the biobanking market based on the application has also been provided in the report. This includes therapeutics and research. According to the report, research accounted for the largest market share.
End-User Insights:
Academic Institutions
Pharma and Biotech Companies
A detailed breakup and analysis of the biobanking market based on the end-user has also been provided in the report. This includes academic institutions and pharma and biotech companies. According to the report, academic institutions accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for biobanking. Some of the factors driving the Europe biobanking market included rising advancements in the stem cell and regenerative medicine research, increasing awareness about stem cell therapies, high demand for automated alarm monitoring devices, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global biobanking market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., VWR Corporation (Avantor Inc.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global biobanking market in 2022?
2. What is the expected growth rate of the global biobanking market during 2023-2028?
3. What are the key factors driving the global biobanking market?
4. What has been the impact of COVID-19 on the global biobanking market?
5. What is the breakup of the global biobanking market based on the specimen type?
6. What is the breakup of the global biobanking market based on the biobank type?
7. What is the breakup of the global biobanking market based on the application?
8. What is the breakup of the global biobanking market based on the end user?
9. What are the key regions in the global biobanking market?
10. Who are the key players/companies in the global biobanking market?
Biobanking refers to the process wherein samples of bodily fluid or tissue are collected, stored, annotated, and redistributed for research to improve the understanding of health and disease. It is a reliable hub of samples and enables access to a pool of high-quality samples and associated data. It is essential for the diagnosis and production of medicines for numerous disorders. It provides a basis for improving personalized medical approaches wherein effective biomarker identification is vital for disease diagnosis and prognosis. It serves as a mediator between donor and researcher for numerous research and different studies. It has high-quality control and assists in improving the reproducibility of various experiments. It also offers data generated through biosamples that is crucial for the digital transformation of health systems. As a result, biobanking is widely utilized in drug and biomarker development, clinical care for therapy, and clinical trials monitoring for the effects of drugs on eventual outcomes across the globe.
Biobanking Market Trends:
At present, the rising demand for biobanking due to the increasing number of genomic research activities represents one of the key factors supporting the growth of the market. Besides this, the growing number of biobanks across the globe, due to its potential to enhance the reproductivity and meaning of data generated by biomedical research, is offering a positive market outlook. Additionally, there is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, cancer, heart attack, and respiratory disorders, among the masses around the world. This, coupled with the increasing demand for biobanking to develop diagnostics that can effectively identify pathogens, is propelling the growth of the market. Apart from this, the rising expenditure in advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, is offering lucrative growth opportunities to industry investors. Moreover, the increasing demand for biospecimens from clinical labs to develop assays for genetic testing is positively influencing the market. In addition, the growing focus on virtual biobank that minimizes time constraints, generates high revenue, and allows researchers to conduct the research smoothly is contributing to the growth of the market. Furthermore, key players are introducing a biobank software solution that assists in gaining visibility and improving the quality of the service provided to customers, which is strengthening the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on specimen type, biobank type, application and end user.
Specimen Type Insights:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others
The report has provided a detailed breakup and analysis of the biobanking market based on the specimen type. This includes blood products, solid tissue, cell lines, nucleic acid, and others. According to the report, blood products represented the largest segment.
Biobank Type Insights:
Population-based Biobanks
Disease-oriented Biobanks
A detailed breakup and analysis of the biobanking market based on the biobank type has also been provided in the report. This includes population-based biobanks and disease-oriented biobanks. According to the report, disease-oriented biobanks accounted for the largest market share.
Application Insights:
Therapeutics
Research
A detailed breakup and analysis of the biobanking market based on the application has also been provided in the report. This includes therapeutics and research. According to the report, research accounted for the largest market share.
End-User Insights:
Academic Institutions
Pharma and Biotech Companies
A detailed breakup and analysis of the biobanking market based on the end-user has also been provided in the report. This includes academic institutions and pharma and biotech companies. According to the report, academic institutions accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for biobanking. Some of the factors driving the Europe biobanking market included rising advancements in the stem cell and regenerative medicine research, increasing awareness about stem cell therapies, high demand for automated alarm monitoring devices, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global biobanking market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., VWR Corporation (Avantor Inc.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global biobanking market in 2022?
2. What is the expected growth rate of the global biobanking market during 2023-2028?
3. What are the key factors driving the global biobanking market?
4. What has been the impact of COVID-19 on the global biobanking market?
5. What is the breakup of the global biobanking market based on the specimen type?
6. What is the breakup of the global biobanking market based on the biobank type?
7. What is the breakup of the global biobanking market based on the application?
8. What is the breakup of the global biobanking market based on the end user?
9. What are the key regions in the global biobanking market?
10. Who are the key players/companies in the global biobanking market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BIOBANKING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY SPECIMEN TYPE
6.1 Blood Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tissue
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY BIOBANK TYPE
7.1 Population-based Biobanks
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Disease-oriented Biobanks
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Therapeutics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic Institutions
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharma and Biotech Companies
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Brooks Automation Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bay Biosciences LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boca Biolistics
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Ctibiotech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Cureline Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Firalis
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Greiner Bio-One International GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Hamilton Company
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Merck KGaA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 ProteoGenex Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 VWR Corporation (Avantor Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BIOBANKING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY SPECIMEN TYPE
6.1 Blood Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tissue
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY BIOBANK TYPE
7.1 Population-based Biobanks
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Disease-oriented Biobanks
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Therapeutics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic Institutions
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharma and Biotech Companies
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Brooks Automation Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bay Biosciences LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boca Biolistics
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Ctibiotech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Cureline Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Firalis
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Greiner Bio-One International GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Hamilton Company
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Merck KGaA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 ProteoGenex Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 VWR Corporation (Avantor Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Biobanking Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2023-2028
Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2023-2028
Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Biobanking Market: Competitive Structure
Table 8: Global: Biobanking Market: Key Players
Table 1: Global: Biobanking Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2023-2028
Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2023-2028
Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Biobanking Market: Competitive Structure
Table 8: Global: Biobanking Market: Key Players
LIST OF FIGURES
Figure 1: Global: Biobanking Market: Major Drivers and Challenges
Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2022
Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2022
Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2022
Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2022
Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2022
Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Biobanking Industry: SWOT Analysis
Figure 81: Global: Biobanking Industry: Value Chain Analysis
Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis
Figure 1: Global: Biobanking Market: Major Drivers and Challenges
Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2022
Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2022
Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2022
Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2022
Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2022
Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Biobanking Industry: SWOT Analysis
Figure 81: Global: Biobanking Industry: Value Chain Analysis
Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis
